You are here

A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children

Last updated on February 18, 2019

FOR MORE INFORMATION
Study Location
Childrens Hospital Los Angeles
Los Angeles, California, 90027 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Invasive Aspergillosis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
2-17 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Immunocompromised with clinically compatible illness.

- Diagnosis of proven or probable or possible Invasive Aspergillosis (based on a
modified version of the revised EORTC/MSG consensus definitions).

- Diagnosis of infection due to Scedosporium or Fusarium species.

- Male and female from 2 to 17 years of age.

- Females with childbearing potential must have negative pregnancy test and be using
appropriate contraception.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Allergy or hypersensitivity to the azole drugs.

- Female subjects who are pregnant or lactating.

- Patients who received more than four days of antifungal drugs to treat the current
episode of invasive aspergillosis or rare mold infection.

- Received within 24 hours prior to enrollment drugs that may cause QT interval
prolongation.

- Significant liver, kidney or heart dysfunction.

- Not expected to survive for at least 5 days.

NCT00836875
Pfizer
Terminated
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now